Diana Hausman
Directeur Technique/Scientifique/R&D chez ZENTALIS PHARMACEUTICALS, INC.
Fortune : 4 M $ au 30/04/2024
Postes actifs de Diana Hausman
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNEERING CORPORATION | Directeur/Membre du Conseil | 18/01/2022 | - |
Independent Dir/Board Member | 18/01/2022 | - | |
ZENTALIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 19/01/2024 | - |
Directeur/Membre du Conseil | 08/05/2023 | 19/01/2024 | |
Independent Dir/Board Member | 08/05/2023 | 19/01/2024 | |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - | - |
Historique de carrière de Diana Hausman
Anciens postes connus de Diana Hausman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Link Immunotherapeutics, Inc.
Link Immunotherapeutics, Inc. Medical/Nursing ServicesHealth Services Link Immunotherapeutics, Inc. is a holding company, which engages in combination therapies. Its biotechnology is dual biscpecifics. The company was founded in 2019 and is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | 01/03/2022 | 01/10/2023 |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | 01/06/2021 | 01/03/2022 |
ZYMEWORKS INC. | Directeur Technique/Scientifique/R&D | 01/06/2016 | 15/05/2021 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/06/2016 | 15/04/2021 |
CASCADIAN THERAPEUTICS INC (USA) | Directeur Technique/Scientifique/R&D | 21/12/2009 | 01/04/2016 |
Corporate Officer/Principal | 02/09/2009 | 21/12/2009 | |
░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Diana Hausman
Princeton University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 13 |
Canada | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 8 |
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
IMMUNEERING CORPORATION | Health Technology |
ZYMEWORKS INC. | Health Technology |
ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 8 |
---|---|
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Link Immunotherapeutics, Inc.
Link Immunotherapeutics, Inc. Medical/Nursing ServicesHealth Services Link Immunotherapeutics, Inc. is a holding company, which engages in combination therapies. Its biotechnology is dual biscpecifics. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Services |
- Bourse
- Insiders
- Diana Hausman
- Expérience